Please login to the form below

Not currently logged in
Email:
Password:

Novo Nordisk bolsters management team

Appoints Camilla Sylvest and Doug Langa

Camilla SylvestDanish pharmaceutical company Novo Nordisk has appointed Camilla Sylvest (pictured right) as its executive vice president in charge of commercial strategy and corporate affairs.

At the helm of this new unit she will be responsible for the company’s corporate functions within marketing, market access, strategy, communications, stakeholder relations and sustainability.

Prior to her new role, Sylvest was the company’s senior vice president in charge of its Chinese operations since 2015.

Lars Fruergaard Jørgensen, president and CEO at Novo Nordisk, said: “During her more than 20 years in Novo Nordisk, Camilla has consistently delivered strong business results, fostered strong relations with stakeholders and demonstrated a natural ability to rally her organisations around key priorities.

“This makes me very confident in her ability to successfully drive our commercial strategies as well as our strategies Doug Langafor developing Novo Nordisk as a responsible corporation focused on the needs of the patients we serve.”

Additionally, Doug Langa (pictured left), senior vice president, head of North America operations and president of Novo Nordisk Inc, is promoted to executive vice president.

He joined the company in 2011 and has over 25 years’ experience in the pharmaceutical and medical device industry.

Both Sylvest and Langa will report to Jørgensen.

17th August 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics